H.R. 2821
Requires FDA rule on non-animal drug testing terms
Tells the FDA to publish a rule within one year that swaps mentions of animal tests for nonclinical tests in its rules for new drug applications.
- Replaces animal test, data, and study wording with nonclinical wording in FDA drug rules
- Applies to FDA rules for investigational new drug applications
- Rule must be published within one year of the bill becoming law
- Rule takes effect right away as an interim final rule
Passed the House · Senate's turn